Trial intelligence / Profile preview

Effect of aprepitant on postoperative nausea and vomiting after cholecystectomy surgery

IRCT20221110056459N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2023; status: completed.

02

Drugs

aprepitant
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on IRCT20221110056459N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20221110056459N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call